Sanofi has announced that the European Commission has granted marketing authorization in Europe for Toujeo (insulin glargine [rDNA origin] injection,...
Sanofi has announced that the FDA has accepted for review the company�s New Drug Application (NDA) for Toujeo (insulin glargine...
Sanofi has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has...